Human Immunoglobulin (Zhongke Biopharmaceutical)

人免疫球蛋白(中科生物)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Immunoglobulin (Zhongke Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMeaslesHepatitis, Viral, Human
Global Approved IndicationsMeaslesHepatitis, Viral, Human
Approved Indications in ChinaMeaslesHepatitis, Viral, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2002/08/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMeaslesHepatitis, Viral, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A